Yüklüyor......
Treatment With Bevacizumab Plus Carboplatin for Recurrent Malignant Glioma
OBJECTIVE: To estimate overall survival (OS), progression-free survival (PFS), imaging responses, and toxicities of bevacizumab plus carboplatin for the treatment of recurrent malignant glioma. The secondary objective was to estimate the agreement between post-contrast T1-weighted and T2-weighted ma...
Kaydedildi:
| Yayımlandı: | Neurosurgery |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905718/ https://ncbi.nlm.nih.gov/pubmed/20559095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1227/01.NEU.0000370918.51053.BC |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|